angiotensin ii has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Berthelot, JM; Drouet, L; Lioté, F | 1 |
1 review(s) available for angiotensin ii and Mucocutaneous Lymph Node Syndrome
Article | Year |
---|---|
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dipyridamole; Humans; Immunoglobulins, Intravenous; Interferons; Membrane Proteins; Mice; Mucocutaneous Lymph Node Syndrome; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Signal Transduction; Thrombosis | 2020 |